NCT02491632 2026-03-18
Physical Activity and Dexamethasone in Reducing Cancer-Related Fatigue in Patients With Advanced Cancer
M.D. Anderson Cancer Center
Phase 2/3 Active not recruiting
Clinical Trials
25 trialsNCT03021486 2026-03-18
Haloperidol With or Without Chlorpromazine in Treating Delirium in Patients With Advanced, Metastatic, or Recurrent Cancer
M.D. Anderson Cancer Center
Phase 2/3 Active not recruiting
NCT05665348 2026-03-09
TRIPLET
Federation Francophone de Cancerologie Digestive
Phase 2/3 Completed
NCT07426094 2026-02-23
PRO-BOOST-N
Affidea Nu-med Center of Oncological DIagnostics and Therapy
Phase 2/3 Not yet recruiting
NCT03927885 2026-02-19
Open Labeled Placebo in Reducing Cancer Related Fatigue in Patients With Advanced Cancer
M.D. Anderson Cancer Center
Phase 2/3 Active not recruiting
NCT03743649 2025-12-26
Haloperidol and Lorazepam in Controlling Symptoms of Persistent Agitated Delirium in Patients With Advanced Cancer Undergoing Palliative Care
M.D. Anderson Cancer Center
Phase 2/3 Active not recruiting
NCT06783140 2025-12-05
PLATINUM-CAN
University Health Network, Toronto
Phase 2/3 Recruiting
NCT06100367 2025-12-02
11C-Metomidate PET/CT for Endocrine Hypertension and Characterisation of Adrenal Tumours
Changi General Hospital
Phase 2/3 Active not recruiting
NCT01861938 2025-10-02
Modified Melanoma Vaccine for High Risk or Low Residual Disease Patients
Hadassah Medical Organization
Phase 2/3 Withdrawn
NCT03295565 2022-04-15
OSTRICh
The Netherlands Cancer Institute
Phase 2/3 Completed
NCT01437514 2021-06-07
Effective Study of Preoperative Short-course Radiotherapy for the Advanced Resectable Rectal Cancer
West China Hospital
Phase 2/3 Terminated
NCT04890522 2021-05-18
An Open-label, Multicentre, Phase II/III RCT of PFLL Versus GP Combined With JS001 as the First-line Therapy for mNPC
Sun Yat-sen University
Phase 2/3 Not yet recruiting
NCT03031444 2021-02-01
PARECEC
Peking University Cancer Hospital & Institute
Phase 2/3 Completed
NCT04710290 2021-01-25
A Cohort Study of Beta-Glucan or Beta-Glucan Compound in Metastatic Cancers
E-DA Hospital
Phase 2/3 Unknown
NCT03909724 2020-11-13
SUNRISE-CRC
Amsterdam UMC, location VUmc
Phase 2/3 Unknown
NCT00212615 2020-11-06
XELOX III. Xeloda in Combination With Eloxatin for Patients With Advanced or Metastatic Colorectal Cancer
Odense University Hospital
Phase 2/3 Completed
NCT03610100 2019-10-29
ACELARATE
The Clatterbridge Cancer Centre NHS Foundation Trust
Phase 2/3 Suspended
NCT03936205 2019-05-14
Dexmedetomidine Addition to Morphine in Patients With Metastatic Cancer
Hotel Dieu de France Hospital
Phase 2/3 Completed
NCT02711007 2018-04-23
Apatinib for Advanced Osteosarcoma After Failure of Standard Multimodal Therapy
Peking University People's Hospital
Phase 2/3 Completed
NCT01782274 2017-10-12
Proteome-based Immunotherapy of Brain Metastases From Breast Cancer
NeuroVita Clinic
Phase 2/3 Unknown
NCT00684216 2017-09-14
Second-line Endocrine Treatment Followed by Capecitabine Versus Capecitabine Followed by Endocrine Treatment in Patients With Metastatic ER Positive Breast Cancer
The Netherlands Cancer Institute
Phase 2/3 Terminated
NCT02208804 2016-11-09
SIM
UMC Utrecht
Phase 2/3 Unknown
NCT01830231 2014-01-28
Cabazitaxel vs. Vinflunine in Metastatic or Locally Advanced Transitional Cell Carcinoma of the Urothelium (TCCU)
Associació per a la Recerca Oncologica, Spain
Phase 2/3 Unknown
NCT00127387 2012-06-26
Enbrel Versus Placebo With Radiation Therapy to Combat Fatigue and Cachexia
The University of Texas Health Science Center at San Antonio
Phase 2/3 Terminated
NCT00561522 2010-07-21
Capecitabine to Prevent Recurrence of Hepatocellular Carcinoma After Curative Resection
Fudan University
Phase 2/3 Unknown